Innate Pharma has signed a co-development and commercialization agreement with AstraZeneca
Posted on 28 April 2015
Innate Pharma has signed a co-development and commercialization agreement with AstraZeneca
Posted on 28 April 2015
Celgene has entered into a strategic collaboration with MedImmune to develop and commercialize an anti-PD-L1 inhibitor, MEDI4736, for hematologic malignancies
Posted on 22 April 2015
Teva Pharmaceutical announced a proposal to acquire all of the outstanding shares of Mylan in a transaction valued at $40 billion
Posted on 21 April 2015
Curadev Pharma has entered into a research collaboration and license agreement with Roche for development and commercialization of IDO1 and TDO inhibitors
Posted on 21 April 2015
TetraLogic and Merck will collaborate on a Phase 1 study
Posted on 20 April 2015
Center for iPS Cell Research Application (CiRA) of Kyoto University and Takeda Pharmaceutical will work together to develop clinical applications of induced pluripotent stem cells
Posted on 20 April 2015
Eli Lilly and Bristol-Myers Squibb announced that the companies have agreed to transfer rights to Erbitux (cetuximab) in North America
Posted on 15 April 2015
Ventana Medical Systems has entered into master collaboration agreement with Astellas Pharma to develop novel automated tissue diagnostics
Posted on 15 April 2015
Abbott and Sekisui announce an agreement to offer coagulation testing solutions for laboratories worldwide
Posted on 14 April 2015
Ichor Medical Systems has entered into a product development collaboration and worldwide license agreement with Janssen Pharmaceuticals